News
The Exciting Potential of Antibody-Drug Conjugates in Lung Cancer
MedPage Today brought together three expert leaders for a virtual roundtable discussion on lung cancer: Moderator Roy Herbst, MD, PhDopens in a new tab or window, was joined by Anne Chiang, MD, PhDopens in a new tab or window, and So Yeon Kim, MDopens in a new tab or window, all from the Yale Cancer Center in New Haven, Connecticut.
This final of four exclusive episodes looks at the exciting ongoing development of antibody-drug conjugates (ADCs) in non-small cell lung cancer (NSCLC). You can see other videos in this series hereopens in a new tab or window.
Source: MedPage Today